Panacea Biotec informs about press release

10 Jun 2020 Evaluate

Panacea Biotec has informed  that the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing and distribution of the Covid-19 vaccine. Under the collaboration, the company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make Covid-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland.  The company has informed that it has enclosed a copy of the Press Release on 10th June 2020 titled ‘Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine’ being issued to the media.

The above information is a part of company’s filings submitted to BSE.


Panacea Biotec Share Price

351.65 -5.70 (-1.60%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×